ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,567.19
1.06%
US Tech 100
19,828.00
0.95%
Dow Jones
39,375.87
0.17%
Brent Oil
86.775
0.00%
Bitcoin
56,547.29
-0.18%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Y mAbs Therapeutics Inc (YMAB)

  7. Y mAbs Therapeutics Inc (YMAB) News

YMAB

Y mAbs Therapeutics (YMAB)

Y mAbs Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:YMAB
DateTimeSourceHeadlineSymbolCompany
05/08/20234:01PMGlobeNewswire Inc.Y-mAbs Reports First Quarter 2023 Financial Results and Recent Corporate Developments and Updates 2023 Financial GuidanceNASDAQ:YMABY mAbs Therapeutics Inc
04/28/20239:00AMGlobeNewswire Inc.Y-mAbs to Announce First Quarter 2023 Financial and Operating Results on May 8, 2023NASDAQ:YMABY mAbs Therapeutics Inc
04/28/20236:23AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:YMABY mAbs Therapeutics Inc
04/18/20239:19AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMABY mAbs Therapeutics Inc
04/18/20239:00AMGlobeNewswire Inc.Y-mAbs Announces Presentation of Naxitamab data at AACRNASDAQ:YMABY mAbs Therapeutics Inc
04/05/20239:10AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMABY mAbs Therapeutics Inc
04/05/20239:00AMGlobeNewswire Inc.Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial of GD2-SADANASDAQ:YMABY mAbs Therapeutics Inc
04/03/20231:47PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:YMABY mAbs Therapeutics Inc
03/30/20234:01PMGlobeNewswire Inc.Y-mAbs Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMABY mAbs Therapeutics Inc
03/21/20234:01PMGlobeNewswire Inc.Y-mAbs to Announce 2022 Financial and Operating Results on March 30, 2023NASDAQ:YMABY mAbs Therapeutics Inc
03/17/20235:45AMPR Newswire (US)YMAB SHAREHOLDER ALERT: Jakubowitz Law Reminds Y-mAbs Shareholders of a Lead Plaintiff Deadline of March 20, 2023NASDAQ:YMABY mAbs Therapeutics Inc
03/15/20235:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Y-mAbs Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 20, 2023 - (NASDAQ: YMAB)NASDAQ:YMABY mAbs Therapeutics Inc
03/13/20239:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMABY mAbs Therapeutics Inc
03/10/20235:45AMPR Newswire (US)YMAB SHAREHOLDER ALERT: Jakubowitz Law Reminds Y-mAbs Shareholders of a Lead Plaintiff Deadline of March 20, 2023NASDAQ:YMABY mAbs Therapeutics Inc
03/08/202310:50PMPR Newswire (US)FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Y-mAbs Therapeutics, Inc. - YMABNASDAQ:YMABY mAbs Therapeutics Inc
03/08/20235:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Y-mAbs Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 20, 2023 - (NASDAQ: YMAB)NASDAQ:YMABY mAbs Therapeutics Inc
03/03/20235:45AMPR Newswire (US)YMAB SHAREHOLDER ALERT: Jakubowitz Law Reminds Y-mAbs Shareholders of a Lead Plaintiff Deadline of March 20, 2023NASDAQ:YMABY mAbs Therapeutics Inc
03/01/20235:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Y-mAbs Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 20, 2023 - (NASDAQ: YMAB)NASDAQ:YMABY mAbs Therapeutics Inc
02/22/202310:50PMPR Newswire (US)FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Y-mAbs Therapeutics, Inc. - YMABNASDAQ:YMABY mAbs Therapeutics Inc
02/22/20235:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Y-mAbs Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 20, 2023 - (NASDAQ: YMAB)NASDAQ:YMABY mAbs Therapeutics Inc
02/15/20235:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Y-mAbs Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 20, 2023 - (NASDAQ: YMAB)NASDAQ:YMABY mAbs Therapeutics Inc
02/10/20235:45AMPR Newswire (US)YMAB SHAREHOLDER ALERT: Jakubowitz Law Reminds Y-mAbs Shareholders of a Lead Plaintiff Deadline of March 20, 2023NASDAQ:YMABY mAbs Therapeutics Inc
02/09/202312:07PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:YMABY mAbs Therapeutics Inc
02/08/202310:50PMPR Newswire (US)FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Y-mAbs Therapeutics, Inc. - YMABNASDAQ:YMABY mAbs Therapeutics Inc
02/08/20235:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Y-mAbs Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 20, 2023 - (NASDAQ: YMAB)NASDAQ:YMABY mAbs Therapeutics Inc
02/03/20235:45AMPR Newswire (US)YMAB SHAREHOLDER ALERT: Jakubowitz Law Reminds Y-mAbs Shareholders of a Lead Plaintiff Deadline of March 20, 2023NASDAQ:YMABY mAbs Therapeutics Inc
02/02/202312:45PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMABY mAbs Therapeutics Inc
02/02/20239:00AMGlobeNewswire Inc.Y-mAbs and the European Medicines Agency Reach Agreement on the Pediatric Investigation Plan for NaxitamabNASDAQ:YMABY mAbs Therapeutics Inc
02/01/202310:50PMPR Newswire (US)FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Y-mAbs Therapeutics, Inc. - YMABNASDAQ:YMABY mAbs Therapeutics Inc
02/01/20235:45AMPR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Y-mAbs Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 20, 2023 - (NASDAQ: YMAB)NASDAQ:YMABY mAbs Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:YMAB

Your Recent History

USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
SPZI
Spooz (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
NASDAQ
NVDA
NVIDIA
NASDAQ
TSLA
Tesla
AMEX
SPY
SPDR S&P 500
USOTC
PSRU
Valiant Eagle (PK)
USOTC
ENZC
Enzolytics (PK)
COIN
SHIBUSD
SHIBA INU
USOTC
SFRX
Seafarer Exploration (PK)
USOTC
BLEG
Branded Legacy (PK)
USOTC
AXXA
Exxe (PK)
USOTC
GTVH
Golden Triangle Ventures (PK)
USOTC
ERHE
ERHC Energy (CE)
USOTC
CLNV
Clean Vision (QB)
USOTC
NSAV
Net Savings Link (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved